Frazier Healthcare Partners has refinanced Orthotic Holdings Inc.
Orthotic Holdings Inc. (OHI) is a leading manufacturer of branded, high-quality and predominantly custom products for treatment of conditions associated with the lower extremities, including custom foot orthotics, custom ankle foot orthotics, therapeutic footwear and compression hosiery. The company’s products are offered under seven distinct brands that are well-known in the healthcare provider community. OHI’s products are offered through a vast network of over 10,000 healthcare providers as well as leading footwear distributors and direct-to-consumer.
Tom Andrus, Chief Financial Officer of OHI, commented, “Lincoln’s tight execution and expertise through all phases of the process made this refinancing a great experience for all parties involved.”
Lincoln acted as the exclusive financial advisor to OHI, working closely with the management team and shareholders throughout the process to close the bespoke financing. This transaction provided the company with additional financial flexibility, while it continues to serve as a market leader in the lower extremity orthotics space. Lincoln provided capital advisory expertise and managed the marketing, negotiation, due diligence and all business phases of the transaction. The terms of the transaction were not disclosed.
Lincoln identified and fostered dialogue with the best potential capital partners. They provided thoughtful advice, clean execution and senior-level dedication to raise a bespoke capital solution that will allow us to take OHI through its next phase of our value creation plan.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Varsity Healthcare Partners on the sale of Angels of Care Pediatric Home Health to Nautic Partners
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.